Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Clinical Practice Guideline Series Update

Blissitt, Patricia A.

Journal of Neuroscience Nursing: October 2013 - Volume 45 - Issue 5 - p 317
doi: 10.1097/JNN.0b013e3182a1cdee
Clinical Practice Guidelines

ABSTRACT Approximately 20 per 100,000 people in the United States are currently living with myasthenia gravis (MG). MG is a chronic condition that occurs in all genders, ethnicities, and ages. The result of a defect at the neuromuscular junction, MG is characterized by fluctuating muscle weakness and fatigue. The purpose of the first edition of this American Association of Neuroscience Nurses’ Clinical Practice Guideline is to summarize what is currently known about MG and to provide the reader with nursing-specific recommendations based on supporting evidence from nursing and other disciplines. Nursing Management of the Patient with Myasthenia Gravis includes information on epidemiology; types and classification of MG; pathophysiology; clinical features; clinical course; diagnostic tests; assessment; pharmacological, immunological, and surgical management; and the nurses’ pivotal role in the care of the patient with MG.

Supplemental Digital Content is available in the text

Questions or comments about this article may be directed to Patricia A. Blissit, RN PhD CCRN CNRN CCNS CCM ACNS-BC at She is the Editor of the American Association of Neuroscience Nurses Clinical Practice Guideline Series.

The author declares no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of the article on the journal’s Web site (

© 2013 American Association of Neuroscience Nurses